期刊文献+

糖化血红蛋白在糖尿病一级预防中的临床应用及研究 被引量:2

Clinical application and research on glycolated hemoglobin of primary protection of diabetes
原文传递
导出
摘要 目的:探讨糖化血红蛋白参考阈值在糖尿病一级预防中的应用价值。方法:检测重点人群糖化血红蛋白,按结果分为四个区间;根据WHO(1999)糖尿病诊断标准分区间试验,并分为五型糖耐量并统计学处理。结果:凉州区重点人群糖尿病发病率为27.4%,糖调节受损发病率为53.1%。在6.0%≤HbA1C<6.5%区间其糖尿病发病率明显高于5.0%≤HbA1C<6.0%区间。前者糖调节受损发病率69.8%。后者71.2%。前者以空腹血糖受损与DM发病为主占32.3%与28%,后者以糖耐量受损发病为主占58.4%。强化生活方式干预五年,糖尿病发病率下降42.9%。结论:在6.0%≤HbA1C<6.5%区间以干预、治疗空腹血糖受损与筛查DM为主。在5.0%≤HbA1Cc<6.0%区间以干预、治疗糖耐量受损为主。强化生活方式干预对预防糖尿病具决定性作用。 Objective:In order to evaluate the application value of the glycolated hemoglobin reference threshold in the primary prevention of diabetes.Methods: The detection for the glycolated hemoglobin of the focal groups is divided into four groups according to the result: The test is performanced according to the experiment of WHO(1999) on dividing of diagnostic standard,the results are divided into five groups of carbohydrate tolerance and analyzed by statistical method.Results: The incidence of the diabetes of the focal group in the Liang Zhou region is 27.4%,the incidence of IGR is 53.1%.The incidence of interval of 6.0%≤HbA1C6.5% is distinctly higher than 5.0%≤HbA1C6.0%.The incidence of IGR of the former and is respectively 69.8% and 71.2%.The former is based on the principle of IFG and DM which is respectively 32.3% and 28%;the latter is based on the principle of IGT which accounts for 58.4%.The incidence of the diabetes is reduced by 42.9% when the enhancing intervene the patients′ life style are taken to the patients for 5 years.Conclusion: In the interval of 6.0%≤HbA1C6.5%,the patients would be treated based on the principle of intervene,curing IFG and investigating of DM.In the interval of 5.0%≤HbA1C6.0%,the treatment would be based on the principle of intervene and curing IGT.At last,enhancing intervene the patients′ life style plays the decisive role in the treatment.
出处 《中国卫生检验杂志》 CAS 2010年第12期3467-3469,共3页 Chinese Journal of Health Laboratory Technology
关键词 糖化血红蛋白 糖尿病 糖调节受损 一级预防 Glycolated hemoglobin Diabetes IGR Primary preventio
  • 相关文献

参考文献3

  • 1周沂,府伟灵.临床生物化学与检验[M].全国高等学校教材(第4版),北京:人民卫生出版社,2008:38-61.
  • 2刘小兰.国际专家委员会推荐糖尿病诊断的新标准-HbA1C[N].北京:医学参考报-检验医学频道,2009:总第138期第1版.
  • 3郭健.统一糖化血红蛋白检测标准势在必行[N].北京:科学时报,2005:第6期三版.

同被引文献22

  • 1中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2010 年版)[M].北京:北京大学医学出版社,2011:13.
  • 2陈灏珠.实用内科学[M]北京:人民卫生出版社,20051026.
  • 3Mann DM,Carson AP,Shimbo D. Impact of A 1 C screening criterion on the diagnosis of pre-diabetes among U.S.adults[J].{H}DIABETES CARE,2010,(1 0):2190-2195.
  • 4Heianza Y,Hara S,Arase Y. HbA 1 c 5.7-6.4% and impaired fasting plasma glucose for diag-nosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3):a longitudinal cohort study[J].{H}LANCET,2011,(9786):147-155.
  • 5Rowley KG,Daniel M,O′Dea K. Screening for diabetes in Indigenous populations using glycated hae-moglobin:sensitivity,specificity,post-test likelihood and risk of disease[J].{H}Diabetic Medicine,2005,(07):833-839.
  • 6Clinical and Laboratory Standards Institute. User Verification of Performance for Precision and Trueness; Approved Guideline-Sec- ond Edition[S]. EP15-A2, CLSI,20OS:I-6d-.
  • 7中华人民共和国卫生行业标准(WS/I"408-2012).临床化学设备线性评价指南[S].(2012-12-25)[2013-08-01].http://www.nhfpc.goV.cn/zwgkz#s9492/wsbz2.sbtml.
  • 8中华人民共和国卫生行业标准(wsrr402-2012).临床实验室检验项目参考区间的制定[s].(2012-12-24)[2013-08-01].http://www.nhfpc.gov.cn/zwgkzt/s9492/wsbz._2shtml.
  • 9张秀明,杨有业.实验室统计学基础.见:杨有业,张秀明,主编.临床检验方法学评价[M].北京:人民卫生出版社,2009:204-205.
  • 10纪立农.从ADA2010新指南看HbA1C在糖尿病诊断和筛查中的重要作用[J].中国糖尿病杂志,2010,18(3):161-163. 被引量:28

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部